JD HEALTH INTL LTD Cash Flow Conversion Efficiency

Latest as of June 2023: 0.004x

JD HEALTH INTL LTD cash flow conversion efficiency. Based on the latest financial reports, JD HEALTH INTL LTD (8ZN) has a cash flow conversion efficiency ratio of 0.004x as of June 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€184.04 Million ≈ $215.16 Million USD) by net assets (€48.69 Billion ≈ $56.93 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of JD HEALTH INTL LTD (2019–2025)

Cash flow conversion efficiency of JD HEALTH INTL LTD from 2019 to 2025. This chart illustrates how JD HEALTH INTL LTD's cash flow conversion efficiency has evolved over time, based on yearly financial data. View latest JD HEALTH INTL LTD stock price today for real-time trading data and today's change.

JD HEALTH INTL LTD Cash Flow Conversion Ratio Explained

JD HEALTH INTL LTD cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

JD HEALTH INTL LTD Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of JD HEALTH INTL LTD ranked by their cash flow conversion efficiency. Also see how much is JD HEALTH INTL LTD worth for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Cipla Limited NSE:CIPLA	0.041x
Renaissancere Holdings Ltd NYSE:RNR	0.037x
Demant A/S CO:DEMANT	0.238x
Mueller Industries Inc NYSE:MLI	-0.022x
Nextpower Inc. NASDAQ:NXT	0.047x
Lingyi iTech Guangdong Co SHE:002600	0.086x
MAPFRE S.A.ADR 2 / EO-10 F:CMA	N/A
ZTO Express (Cayman) Inc F:ZTOA	0.049x

Annual Cash Flow Conversion Efficiency for JD HEALTH INTL LTD (2019–2025)

The table below shows the annual cash flow conversion efficiency of JD HEALTH INTL LTD from 2019 to 2025. Review JD HEALTH INTL LTD free cash flow ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	€60.07 Billion ≈ $70.23 Billion	€10.17 Billion ≈ $11.89 Billion	0.169x	+115.95%
2024-12-31	€55.24 Billion ≈ $64.58 Billion	€4.33 Billion ≈ $5.06 Billion	0.078x	-15.91%
2023-12-31	€49.37 Billion ≈ $57.72 Billion	€4.60 Billion ≈ $5.38 Billion	0.093x	-29.26%
2022-12-31	€44.78 Billion ≈ $52.36 Billion	€5.91 Billion ≈ $6.90 Billion	0.132x	+53.18%
2021-12-31	€39.85 Billion ≈ $46.59 Billion	€3.43 Billion ≈ $4.01 Billion	0.086x	-8.67%
2020-12-31	€39.25 Billion ≈ $45.89 Billion	€3.70 Billion ≈ $4.33 Billion	0.094x	+110.57%
2019-12-31	€-459.03 Million ≈ $-536.66 Million	€409.47 Million ≈ $478.71 Million	-0.892x	--

About JD HEALTH INTL LTD

F:8ZN Germany Pharmaceutical Retailers

Market Cap

$16.02 Billion

€13.71 Billion EUR

Market Cap Rank

#1867 Global

#401 in Germany

Share Price

€4.30

Change (1 day)

+4.57%

52-Week Range

€3.55 - €7.60

All Time High

€22.34